Orexo AB - Company Profile

Powered by

All the data and insights you need on Orexo AB in one report.

  • Save hours of research time and resources with
    our up-to-date Orexo AB Strategy Report

  • Understand Orexo AB position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

The following section provides information on Orexo AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Orexo AB's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

James Noble

Chairman Executive Board Since: 2020 Age: 64

Mr. James Noble has been the Chairman of the company since 2020. Prior to this, he served as the Co Founder of Adaptimmune; Chief Executive Officer of Immunocore; and Chairman and Chief Executive Officer of Avidex. Previously, he also served as a Director of Medigene, PowderJect Pharmaceuticals and CuraGen Corporation. Currently, he serves as the Board member of Adaptimmune since 2008 and Board member and Deputy Chairman of GW Pharmaceuticals since 2007.

Read Hide full bio of James Noble

Nikolaj Sorensen

Chief Executive Officer; President Senior Management Since: 2013 Age: 51

Mr. Nikolaj Sorensen has been the President and Chief Executive Officer of the company since 2013. Prior to this, he worked with Pfizer and Boston Consulting Group and has extensive experience in International commerce. He is also a board member of the Swedish Pharmaceutical Industry Association.

Read Hide full bio of Nikolaj Sorensen

Fredrik Jarrsten

Executive Vice President; Chief Financial Officer Senior Management Since: 2022

Mr. Fredrik Jarrsten has been the Chief Financial Officer and Executive Vice President of the company since September 2022. Prior to this, he served as a Chief Financial Officer at Oasmia Pharmaceutical AB and Karolinska Development AB.

Read Hide full bio of Fredrik Jarrsten

Edward Kim, M.D

Chief Medical Officer Senior Management Since: 2022

Mr. Edward Kim has been the Chief Medical Officer of the company since October 2022. Prior to this, he served as a Vice President and Head of Medical Affairs at Biohaven Pharmaceuticals.

Read Hide full bio of Edward Kim, M.D

Cecilia Coupland

Senior Vice President; Head - Operations Senior Management Since: 2019 Age: 47
Gain a 360-degree view of Orexo AB and make more informed decisions for your business Gain a 360-degree view of Orexo AB and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code